Health benefits of resveratrol: Evidence from clinical studies

Resveratrol is a polyphenolic nutraceutical that exhibits pleiotropic activities in human subjects. The efficacy, safety, and pharmacokinetics of resveratrol have been documented in over 244 clinical trials, with an additional 27 clinical trials currently ongoing. Resveretrol is reported to potentially improve the therapeutic outcome in patients suffering from diabetes mellitus, obesity, colorectal cancer, breast cancer, multiple myeloma, metabolic syndrome, hypertension, Alzheimer's disease, stroke, cardiovascular diseases, kidney diseases, inflammatory diseases, and rhinopharyngitis. The polyphenol is reported to be safe at doses up to 5 g/d, when used either alone or as a combination therapy. The molecular…

• IC
  Indian Council of Medical Research

  Award: 3/2/2/43/2018/Online Onco Fship/NCD‐III
• UG
  University Grants Commission

  Award: No. F.30‐112/2015 (BSR)
• DO
  Department of Biotechnology, Government of West Bengal

  Award: DBT/2017/BHU/786
• SA
  Science and Engineering Research Board

  Awards: ECR/2016/000034, PDF/2016/004063